News | May 27, 2025
Akums reports Q4 FY25 with 12.4% revenue growth
Akums invested Rs. 272 crore in capital expenditure during FY25
Akums invested Rs. 272 crore in capital expenditure during FY25
The CDMO upgrade represents a transformational step for Remedium Lifecare
The company's first-ever corporate-level submission to EcoVadis builds on years of operational and environmental excellence
The implementation, spearheaded by Deloitte Consulting, brings together domain expertise and cutting-edge technology
The capital raise will also support debt repayment or prepayment, improving the company's debt-to-equity ratio and overall financial resilience
Centre for Continuous Manufacturing and Advanced Crystallisation (CMAC) aims to accelerate the digital transformation of CMC development and manufacturing approaches
David joins HCTI with a distinguished career of over 22 years of corporate finance experience
The company is targeting a Rs. 1,000 crore finished dosages business within the next five years
Strengthening capabilities in Peptide Therapeutics and CDMO services
Positions Curium as leading manufacturer of Lu-177 isotope
Subscribe To Our Newsletter & Stay Updated
